Publications

Found 47 results
Filters: Keyword is HIV Infections  [Clear All Filters]
2012
Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, Tappero JW, Bukusi EA, Cohen CR, Katabira E et al..  2012.  Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.. N Engl J Med. 367(5):399-410.
Feinberg MB, Ahmed R.  2012.  Born this way? Understanding the immunological basis of effective HIV control. Nat Immunol. 13(7):632-4.
Burton DR, Poignard P, Stanfield RL, Wilson IA.  2012.  Broadly neutralizing antibodies present new prospects to counter highly antigenically diverse viruses.. Science. 337(6091):183-6.
Kwon DS, Angin M, Hongo TC, Law KM, Johnson J, Porichis F, Hart MG, Pavlik DF, Tighe DP, Kavanagh DG et al..  2012.  CD4+ CD25+ regulatory T cells impair HIV-1-specific CD4 T cell responses by upregulating interleukin-10 production in monocytes.. J Virol. 86(12):6586-94.
Klatt NR, Silvestri G.  2012.  CD4+ T cells and HIV: A paradoxical Pas de Deux.. Sci Transl Med. 4(123):123ps4.
Cheng C, Wang L, Wang LS, Gall JGD, Nason M, Schwartz RM, McElrath JM, DeRosa SC, Hural J, Corey L et al..  2012.  Decreased pre-existing Ad5 capsid and Ad35 neutralizing antibodies increase HIV-1 infection risk in the Step trial independent of vaccination.. PLoS One. 7(4):e33969.
Walker BD.  2012.  "Elite controllers" provide clues to keeping HIV infection in check. Interview by Tracy Hampton.. JAMA. 308(4):328-9.
Moldt B, Rakasz EG, Schultz N, Chan-Hui P-Y, Swiderek K, Weisgrau KL, Piaskowski SM, Bergman Z, Watkins DI, Poignard P et al..  2012.  Highly potent HIV-specific antibody neutralization in vitro translates into effective protection against mucosal SHIV challenge in vivo.. Proc Natl Acad Sci U S A. 109(46):18921-5.
Haynes BF, Gilbert PB, McElrath JM, Zolla-Pazner S, Tomaras GD, Alam MS, Evans DT, Montefiori DC, Karnasuta C, Sutthent R et al..  2012.  Immune-correlates analysis of an HIV-1 vaccine efficacy trial.. N Engl J Med. 366(14):1275-86.
Chahroudi A, Silvestri G.  2012.  IRIS: the unfortunate rainbow of HIV.. Blood. 119(13):2971-2.
Wright JK, Brumme ZL, Julg B, van der Stok M, Mncube Z, Gao X, Carlson JM, Goulder PJR, Walker BD, Brockman MA et al..  2012.  Lack of association between HLA class II alleles and in vitro replication capacities of recombinant viruses encoding HIV-1 subtype C Gag-protease from chronically infected individuals.. J Virol. 86(2):1273-6.
Barouch DH, Klasse P J, Dufour J, Veazey RS, Moore JP.  2012.  Macaque studies of vaccine and microbicide combinations for preventing HIV-1 sexual transmission.. Proc Natl Acad Sci U S A. 109(22):8694-8.
Chahroudi A, Bosinger SE, Vanderford TH, Paiardini M, Silvestri G.  2012.  Natural SIV hosts: showing AIDS the door.. Science. 335(6073):1188-93.
Montero M, Gulzar N, Klaric K-A, Donald JE, Lepik C, Wu S, Tsai S, Julien J-P, Hessell AJ, Wang S et al..  2012.  Neutralizing epitopes in the membrane-proximal external region of HIV-1 gp41 are influenced by the transmembrane domain and the plasma membrane.. J Virol. 86(6):2930-41.
Wilkinson P, Filali-Mouhim A, Li S, Ahlers J, Schatzle J, Pulendran B, Sekaly R-P, Cameron MJ.  2012.  An open-ended plea for the development of a global database of HIV vaccine responses.. Curr Opin HIV AIDS. 7(1):10-6.

Pages